Pneumococcal 13-valent Conjugate Vaccine
GPTKB entity
Statements (44)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
adults
children elderly infants |
| gptkbp:alsoKnownAs |
gptkb:PCV13
|
| gptkbp:approvalYear |
2010
|
| gptkbp:approvedBy |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:brand |
gptkb:Prevnar_13
|
| gptkbp:broadcastOn |
4-dose series for infants
|
| gptkbp:category |
vaccine
essential medicine pediatric vaccine adult vaccine |
| gptkbp:contains |
gptkb:CRM197_protein_carrier
polysaccharide antigens 13 serotypes of Streptococcus pneumoniae |
| gptkbp:contraindication |
severe allergic reaction to previous dose
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pneumococcal 13-valent Conjugate Vaccine
|
| gptkbp:includedIn |
childhood immunization schedule
|
| gptkbp:indication |
immunocompromised individuals
asplenic patients patients with chronic illnesses |
| gptkbp:notEffectiveAgainst |
all pneumococcal serotypes
|
| gptkbp:prevention |
gptkb:pneumonia
meningitis pneumococcal disease bacteremia Streptococcus pneumoniae infection |
| gptkbp:reduces |
antibiotic-resistant infections
nasopharyngeal carriage of vaccine serotypes |
| gptkbp:replacedBy |
gptkb:Pneumococcal_7-valent_Conjugate_Vaccine
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
fatigue injection site pain irritability |
| gptkbp:storage |
2-8°C
|
| gptkbp:type |
vaccine
|
| gptkbp:usedIn |
over 100 countries
|
| gptkbp:WHOModelListOfEssentialMedicines |
true
|
| gptkbp:bfsParent |
gptkb:PCV13
|
| gptkbp:bfsLayer |
5
|